Noise Induced Hearing Loss
9
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
FX-322 in Adults With Stable Sensorineural Hearing Loss
FX-322 in Adults With Acquired Sensorineural Hearing Loss
Determination of the Effects of Noise Level in the Operating Room
The Effect of Acupuncture on Patients With Noise-induced Hearing Loss
FX-322 in Adults With Age-Related Sensorineural Hearing Loss
FX-322 in Adults With Severe Sensorineural Hearing Loss
ABR Characteristics and Salivary Cortisone Concentration in Noise-exposed Workers
A Phase 2b Study of SPI-1005 to Prevent Acute Noise Induced Hearing Loss